title: Hydrophilic nasal gel of lidocaine hydrochloride. 1st Communication: Preparation, formulation optimization and in vitro release study.
abstract: Intranasal lidocaine hydrochloride (LID, CAS 73-78-9) has been shown useful in the control of a series of symptoms such as migraine, cluster headache and trigeminal neuralgia in clinical studies. However, rapid nasal mucociliary clearance of intranasal solution usually affects its efficiency. In this study, a nasal gel formulation was designed using hydroxypropyl methyl cellulose (HPMC) as mucoadhesive polymer to increase the residence time of LID on the nasal mucosa. Based on the results of a preliminary single factor study, the gel formulation was optimized by central composite design to provide better drug release and bioadhesive intensity. The methods for investigating the gel's bioadhesive intensity and for spectrophotometric determination of LID were established. Then the parameters for the LID in vitro release study such as release medium, release apparatus and rotation rate were decided upon a method of f2 fit factor. The in vitro drug release property of the optimized formulation was proved to comply with the Higuchi equation.
authors.affiliation: Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China.
authors.forename: Kai-Li
authors.initials: KL
authors.lastname: Hu
authors.forename: Ni
authors.initials: N
authors.lastname: Mei
authors.forename: Liang
authors.initials: L
authors.lastname: Feng
authors.forename: Xin-Guo
authors.initials: XG
authors.lastname: Jiang
mesh_terms: D000269:Adhesives; D000281:Administration, Intranasal; D000465:Algorithms; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000818:Animals; D002626:Chemistry, Pharmaceutical; D015195:Drug Design; D004355:Drug Stability; D005079:Excipients; D005260:Female; D005782:Gels; D065347:Hypromellose Derivatives; D007509:Irritants; D008012:Lidocaine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives; D009297:Nasal Mucosa / Q000473:pathology; D015203:Reproducibility of Results; D012995:Solubility; D013056:Spectrophotometry, Ultraviolet; D014982:Xenopus laevis
chemical_list: D000269:Adhesives; D000779:Anesthetics, Local; D005079:Excipients; D005782:Gels; D007509:Irritants; D065347:Hypromellose Derivatives; D008747:Methylcellulose; D008012:Lidocaine